The biopharmaceutical industry is quickly expanding and diversifying its arsenal of advanced treatments based on cell and gene therapies—treatments derived from human beings’ cells and genetic code, with alterations that can help solve human health problems.
Decades of rigorous research and technological advancements in genomics and cell biology have fueled an explosion of new biotherapeutics from new companies, with large numbers of them now reaching the clinical stage.